{"id":"W3167422454","doi":"10.1200/jco.2021.39.15_suppl.tps2681","title":"Phase I study investigating the safety of stereotactic body radiotherapy (SBRT) with anti-PD-1 and anti-IL-8 for the treatment of multiple metastases in advanced solid tumors.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Immunotherapy; Melanoma; Response Evaluation Criteria in Solid Tumors; Ipilimumab; Oncology; Internal medicine; Cabozantinib; Clinical trial; Cancer research; Phases of clinical research; Cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002099684,0.001977302,0.002382589,0.0006893014,0.000526158,0.001114904,0.00146798,0.001824848,0.004835524],"category_scores_gemma":[0.0009522145,0.000888214,0.001653002,0.0005012536,0.001430627,0.001120138,0.0004186053,0.003928031,0.001142647],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001614464,"about_ca_system_score_gemma":0.003025684,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001506513,"about_ca_topic_score_gemma":0.003095897,"domain_scores_codex":[0.9993593,0.0002807084,0.00002600429,0.0001196761,0.00007913697,0.00013518],"domain_scores_gemma":[0.9987173,0.0001385931,0.000338268,0.0001170877,0.00008095605,0.0006078865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6500541,0.2080766,0.004407,0.0008057479,0.001431518,0.0002468119,0.0002756907,0.002970412,0.07906098,0.0003410791,0.004113664,0.04821634],"study_design_scores_gemma":[0.2392787,0.7464643,0.004604112,0.00002088086,0.0003423285,0.0001861087,0.00003970101,0.0009146973,0.006173248,0.0001600818,0.001797583,0.00001824007],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987506,0.001294524,0.001110453,0.0003895294,0.0001661038,0.005873812,0.001842517,0.0001310152,0.001686004],"genre_scores_gemma":[0.9792635,0.001651508,0.003004793,0.0008365597,0.0002430911,0.007273302,0.00366387,0.00006268145,0.004000871],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004835524,"threshold_uncertainty_score":0.0161764,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09879509858647831,"score_gpt":0.4692649152665609,"score_spread":0.3704698166800826,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}